{"entity":{"type":"insider","cik":"0001370042","url":"/insider/0001370042","json_url":"/insider/0001370042.json","name":"STONEPINE CAPITAL, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":15,"first":"2015-11-25","last":"2019-12-12","span_basis":"filed_date"},"name_variants":[{"name":"STONEPINE CAPITAL, L.P.","source":"filing","n_filings":15,"first_seen":"2015-11-25","last_seen":"2019-12-12"}],"transactions":[{"id":8353682,"accession":"0001567619-19-022982","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-19-022982","line_url":"/filing/0001567619-19-022982#line-3","is_derivative":false,"issuer_cik":"0000827809","issuer_name":"NOVELION THERAPEUTICS INC.","issuer_ticker":"NVLNF","issuer_name_source":null,"issuer_url":"/issuer/0000827809","owner_cik":"0001370042","owner_name":"STONEPINE CAPITAL, L.P.","owner_display_name":"STONEPINE CAPITAL, L.P.","owner_url":"/insider/0001370042","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.7,"price_display":"0.70","price_state":"stated","total_value":700.0,"total_display":"700.00","total_whole":"700","shares_owned_after":3909207.0,"shares_owned_after_display":"3,909,207","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-12","filed_date":"2019-12-12","scope":"insider"},{"id":8353677,"accession":"0001567619-19-022982","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-19-022982","line_url":"/filing/0001567619-19-022982#line-2","is_derivative":false,"issuer_cik":"0000827809","issuer_name":"NOVELION THERAPEUTICS INC.","issuer_ticker":"NVLNF","issuer_name_source":null,"issuer_url":"/issuer/0000827809","owner_cik":"0001370042","owner_name":"STONEPINE CAPITAL, L.P.","owner_display_name":"STONEPINE CAPITAL, L.P.","owner_url":"/insider/0001370042","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40.0,"shares_display":"40","price_per_share":0.69,"price_display":"0.69","price_state":"stated","total_value":27.6,"total_display":"27.60","total_whole":"28","shares_owned_after":3908207.0,"shares_owned_after_display":"3,908,207","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-11","filed_date":"2019-12-12","scope":"insider"},{"id":8353673,"accession":"0001567619-19-022982","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-19-022982","line_url":"/filing/0001567619-19-022982#line-1","is_derivative":false,"issuer_cik":"0000827809","issuer_name":"NOVELION THERAPEUTICS INC.","issuer_ticker":"NVLNF","issuer_name_source":null,"issuer_url":"/issuer/0000827809","owner_cik":"0001370042","owner_name":"STONEPINE CAPITAL, L.P.","owner_display_name":"STONEPINE CAPITAL, L.P.","owner_url":"/insider/0001370042","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5202.0,"shares_display":"5,202","price_per_share":0.6916,"price_display":"0.69","price_state":"stated","total_value":3597.7032,"total_display":"3,597.70","total_whole":"3,598","shares_owned_after":3908167.0,"shares_owned_after_display":"3,908,167","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-10","filed_date":"2019-12-12","scope":"insider"},{"id":8018750,"accession":"0001567619-19-022780","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-19-022780","line_url":"/filing/0001567619-19-022780#line-3","is_derivative":false,"issuer_cik":"0000827809","issuer_name":"NOVELION THERAPEUTICS INC.","issuer_ticker":"NVLNF","issuer_name_source":null,"issuer_url":"/issuer/0000827809","owner_cik":"0001370042","owner_name":"STONEPINE CAPITAL, L.P.","owner_display_name":"STONEPINE CAPITAL, L.P.","owner_url":"/insider/0001370042","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4500.0,"shares_display":"4,500","price_per_share":0.7,"price_display":"0.70","price_state":"stated","total_value":3150.0,"total_display":"3,150.00","total_whole":"3,150","shares_owned_after":3902965.0,"shares_owned_after_display":"3,902,965","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-09","scope":"insider"},{"id":8018748,"accession":"0001567619-19-022780","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-19-022780","line_url":"/filing/0001567619-19-022780#line-2","is_derivative":false,"issuer_cik":"0000827809","issuer_name":"NOVELION THERAPEUTICS INC.","issuer_ticker":"NVLNF","issuer_name_source":null,"issuer_url":"/issuer/0000827809","owner_cik":"0001370042","owner_name":"STONEPINE CAPITAL, L.P.","owner_display_name":"STONEPINE CAPITAL, L.P.","owner_url":"/insider/0001370042","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40.0,"shares_display":"40","price_per_share":0.7,"price_display":"0.70","price_state":"stated","total_value":28.0,"total_display":"28.00","total_whole":"28","shares_owned_after":3898465.0,"shares_owned_after_display":"3,898,465","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-06","filed_date":"2019-12-09","scope":"insider"},{"id":8018746,"accession":"0001567619-19-022780","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-19-022780","line_url":"/filing/0001567619-19-022780#line-1","is_derivative":false,"issuer_cik":"0000827809","issuer_name":"NOVELION THERAPEUTICS INC.","issuer_ticker":"NVLNF","issuer_name_source":null,"issuer_url":"/issuer/0000827809","owner_cik":"0001370042","owner_name":"STONEPINE CAPITAL, L.P.","owner_display_name":"STONEPINE CAPITAL, L.P.","owner_url":"/insider/0001370042","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5160.0,"shares_display":"5,160","price_per_share":0.7,"price_display":"0.70","price_state":"stated","total_value":3612.0,"total_display":"3,612.00","total_whole":"3,612","shares_owned_after":3898425.0,"shares_owned_after_display":"3,898,425","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-05","filed_date":"2019-12-09","scope":"insider"},{"id":8769021,"accession":"0001567619-19-022304","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-19-022304","line_url":"/filing/0001567619-19-022304#line-1","is_derivative":false,"issuer_cik":"0000827809","issuer_name":"NOVELION THERAPEUTICS INC.","issuer_ticker":"NVLNF","issuer_name_source":null,"issuer_url":"/issuer/0000827809","owner_cik":"0001370042","owner_name":"STONEPINE CAPITAL, L.P.","owner_display_name":"STONEPINE CAPITAL, L.P.","owner_url":"/insider/0001370042","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":89845.0,"shares_display":"89,845","price_per_share":0.7461,"price_display":"0.75","price_state":"stated","total_value":67033.3545,"total_display":"67,033.35","total_whole":"67,033","shares_owned_after":3893265.0,"shares_owned_after_display":"3,893,265","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-22","filed_date":"2019-11-26","scope":"insider"},{"id":8720921,"accession":"0001567619-19-019667","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-19-019667","line_url":"/filing/0001567619-19-019667#line-1","is_derivative":false,"issuer_cik":"0000827809","issuer_name":"NOVELION THERAPEUTICS INC.","issuer_ticker":"NVLNF","issuer_name_source":null,"issuer_url":"/issuer/0000827809","owner_cik":"0001370042","owner_name":"STONEPINE CAPITAL, L.P.","owner_display_name":"STONEPINE CAPITAL, L.P.","owner_url":"/insider/0001370042","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":0.649,"price_display":"0.65","price_state":"stated","total_value":64900.0,"total_display":"64,900.00","total_whole":"64,900","shares_owned_after":3803420.0,"shares_owned_after_display":"3,803,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-11","filed_date":"2019-10-16","scope":"insider"},{"id":5978483,"accession":"0001567619-18-008828","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-18-008828","line_url":"/filing/0001567619-18-008828#line-1","is_derivative":false,"issuer_cik":"0001251769","issuer_name":"Apollo Endosurgery, Inc.","issuer_ticker":"APEN","issuer_name_source":null,"issuer_url":"/issuer/0001251769","owner_cik":"0001370042","owner_name":"STONEPINE CAPITAL, L.P.","owner_display_name":"STONEPINE CAPITAL, L.P.","owner_url":"/insider/0001370042","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250000.0,"shares_display":"250,000","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":750000.0,"total_display":"750,000.00","total_whole":"750,000","shares_owned_after":2185426.0,"shares_owned_after_display":"2,185,426","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-27","filed_date":"2018-12-31","scope":"insider"},{"id":6078480,"accession":"0001567619-18-008814","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-18-008814","line_url":"/filing/0001567619-18-008814#line-1","is_derivative":false,"issuer_cik":"0001251769","issuer_name":"Apollo Endosurgery, Inc.","issuer_ticker":"APEN","issuer_name_source":null,"issuer_url":"/issuer/0001251769","owner_cik":"0001370042","owner_name":"STONEPINE CAPITAL, L.P.","owner_display_name":"STONEPINE CAPITAL, L.P.","owner_url":"/insider/0001370042","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500000.0,"shares_display":"500,000","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":1500000.0,"total_display":"1,500,000.00","total_whole":"1,500,000","shares_owned_after":2435426.0,"shares_owned_after_display":"2,435,426","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-26","filed_date":"2018-12-28","scope":"insider"},{"id":6207163,"accession":"0001567619-18-006849","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-18-006849","line_url":"/filing/0001567619-18-006849#line-2","is_derivative":false,"issuer_cik":"0001251769","issuer_name":"Apollo Endosurgery, Inc.","issuer_ticker":"APEN","issuer_name_source":null,"issuer_url":"/issuer/0001251769","owner_cik":"0001370042","owner_name":"STONEPINE CAPITAL, L.P.","owner_display_name":"STONEPINE CAPITAL, L.P.","owner_url":"/insider/0001370042","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3230.0,"shares_display":"3,230","price_per_share":3.605,"price_display":"3.60","price_state":"stated","total_value":11644.15,"total_display":"11,644.15","total_whole":"11,644","shares_owned_after":2935426.0,"shares_owned_after_display":"2,935,426","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-21","filed_date":"2018-11-21","scope":"insider"},{"id":6207158,"accession":"0001567619-18-006849","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-18-006849","line_url":"/filing/0001567619-18-006849#line-1","is_derivative":false,"issuer_cik":"0001251769","issuer_name":"Apollo Endosurgery, Inc.","issuer_ticker":"APEN","issuer_name_source":null,"issuer_url":"/issuer/0001251769","owner_cik":"0001370042","owner_name":"STONEPINE CAPITAL, L.P.","owner_display_name":"STONEPINE CAPITAL, L.P.","owner_url":"/insider/0001370042","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":54200.0,"shares_display":"54,200","price_per_share":3.4,"price_display":"3.40","price_state":"stated","total_value":184280.0,"total_display":"184,280.00","total_whole":"184,280","shares_owned_after":2932196.0,"shares_owned_after_display":"2,932,196","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-19","filed_date":"2018-11-21","scope":"insider"},{"id":6428098,"accession":"0001567619-18-005171","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-18-005171","line_url":"/filing/0001567619-18-005171#line-1","is_derivative":false,"issuer_cik":"0001251769","issuer_name":"Apollo Endosurgery, Inc.","issuer_ticker":"APEN","issuer_name_source":null,"issuer_url":"/issuer/0001251769","owner_cik":"0001370042","owner_name":"STONEPINE CAPITAL, L.P.","owner_display_name":"STONEPINE CAPITAL, L.P.","owner_url":"/insider/0001370042","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300000.0,"shares_display":"300,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":1500000.0,"total_display":"1,500,000.00","total_whole":"1,500,000","shares_owned_after":2877996.0,"shares_owned_after_display":"2,877,996","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-02","filed_date":"2018-11-06","scope":"insider"},{"id":6389506,"accession":"0001140361-18-000522","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-18-000522","line_url":"/filing/0001140361-18-000522#line-3","is_derivative":false,"issuer_cik":"0001251769","issuer_name":"Apollo Endosurgery, Inc.","issuer_ticker":"APEN","issuer_name_source":null,"issuer_url":"/issuer/0001251769","owner_cik":"0001370042","owner_name":"STONEPINE CAPITAL, L.P.","owner_display_name":"STONEPINE CAPITAL, L.P.","owner_url":"/insider/0001370042","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6339.0,"shares_display":"6,339","price_per_share":5.7826,"price_display":"5.78","price_state":"stated","total_value":36655.9014,"total_display":"36,655.90","total_whole":"36,656","shares_owned_after":2577996.0,"shares_owned_after_display":"2,577,996","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-03","filed_date":"2018-01-03","scope":"insider"},{"id":6389503,"accession":"0001140361-18-000522","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-000522","line_url":"/filing/0001140361-18-000522#line-2","is_derivative":false,"issuer_cik":"0001251769","issuer_name":"Apollo Endosurgery, Inc.","issuer_ticker":"APEN","issuer_name_source":null,"issuer_url":"/issuer/0001251769","owner_cik":"0001370042","owner_name":"STONEPINE CAPITAL, L.P.","owner_display_name":"STONEPINE CAPITAL, L.P.","owner_url":"/insider/0001370042","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11343.0,"shares_display":"11,343","price_per_share":5.7269,"price_display":"5.73","price_state":"stated","total_value":64960.2267,"total_display":"64,960.23","total_whole":"64,960","shares_owned_after":2571657.0,"shares_owned_after_display":"2,571,657","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-03","scope":"insider"},{"id":6389500,"accession":"0001140361-18-000522","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-000522","line_url":"/filing/0001140361-18-000522#line-1","is_derivative":false,"issuer_cik":"0001251769","issuer_name":"Apollo Endosurgery, Inc.","issuer_ticker":"APEN","issuer_name_source":null,"issuer_url":"/issuer/0001251769","owner_cik":"0001370042","owner_name":"STONEPINE CAPITAL, L.P.","owner_display_name":"STONEPINE CAPITAL, L.P.","owner_url":"/insider/0001370042","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5163.0,"shares_display":"5,163","price_per_share":5.5621,"price_display":"5.56","price_state":"stated","total_value":28717.1223,"total_display":"28,717.12","total_whole":"28,717","shares_owned_after":2560314.0,"shares_owned_after_display":"2,560,314","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-29","filed_date":"2018-01-03","scope":"insider"},{"id":4287037,"accession":"0001140361-17-047619","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-047619","line_url":"/filing/0001140361-17-047619#line-1","is_derivative":false,"issuer_cik":"0001251769","issuer_name":"Apollo Endosurgery, Inc.","issuer_ticker":"APEN","issuer_name_source":null,"issuer_url":"/issuer/0001251769","owner_cik":"0001370042","owner_name":"STONEPINE CAPITAL, L.P.","owner_display_name":"STONEPINE CAPITAL, L.P.","owner_url":"/insider/0001370042","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5287.0,"shares_display":"5,287","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":26435.0,"total_display":"26,435.00","total_whole":"26,435","shares_owned_after":2555151.0,"shares_owned_after_display":"2,555,151","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-26","filed_date":"2017-12-28","scope":"insider"},{"id":4864701,"accession":"0001140361-17-047231","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-17-047231","line_url":"/filing/0001140361-17-047231#line-3","is_derivative":false,"issuer_cik":"0001251769","issuer_name":"Apollo Endosurgery, Inc.","issuer_ticker":"APEN","issuer_name_source":null,"issuer_url":"/issuer/0001251769","owner_cik":"0001370042","owner_name":"STONEPINE CAPITAL, L.P.","owner_display_name":"STONEPINE CAPITAL, L.P.","owner_url":"/insider/0001370042","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":41399.0,"shares_display":"41,399","price_per_share":4.9968,"price_display":"5.00","price_state":"stated","total_value":206862.5232,"total_display":"206,862.52","total_whole":"206,863","shares_owned_after":2549864.0,"shares_owned_after_display":"2,549,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-22","filed_date":"2017-12-22","scope":"insider"},{"id":4864697,"accession":"0001140361-17-047231","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-047231","line_url":"/filing/0001140361-17-047231#line-2","is_derivative":false,"issuer_cik":"0001251769","issuer_name":"Apollo Endosurgery, Inc.","issuer_ticker":"APEN","issuer_name_source":null,"issuer_url":"/issuer/0001251769","owner_cik":"0001370042","owner_name":"STONEPINE CAPITAL, L.P.","owner_display_name":"STONEPINE CAPITAL, L.P.","owner_url":"/insider/0001370042","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":98324.0,"shares_display":"98,324","price_per_share":4.9423,"price_display":"4.94","price_state":"stated","total_value":485946.7052,"total_display":"485,946.71","total_whole":"485,947","shares_owned_after":2508465.0,"shares_owned_after_display":"2,508,465","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-21","filed_date":"2017-12-22","scope":"insider"},{"id":4864689,"accession":"0001140361-17-047231","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-047231","line_url":"/filing/0001140361-17-047231#line-1","is_derivative":false,"issuer_cik":"0001251769","issuer_name":"Apollo Endosurgery, Inc.","issuer_ticker":"APEN","issuer_name_source":null,"issuer_url":"/issuer/0001251769","owner_cik":"0001370042","owner_name":"STONEPINE CAPITAL, L.P.","owner_display_name":"STONEPINE CAPITAL, L.P.","owner_url":"/insider/0001370042","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":45434.0,"shares_display":"45,434","price_per_share":4.4969,"price_display":"4.50","price_state":"stated","total_value":204312.1546,"total_display":"204,312.15","total_whole":"204,312","shares_owned_after":2410141.0,"shares_owned_after_display":"2,410,141","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-20","filed_date":"2017-12-22","scope":"insider"},{"id":4751790,"accession":"0001140361-17-012865","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-012865","line_url":"/filing/0001140361-17-012865#line-1","is_derivative":false,"issuer_cik":"0000879682","issuer_name":"VIVEVE MEDICAL, INC.","issuer_ticker":"VIVE","issuer_name_source":null,"issuer_url":"/issuer/0000879682","owner_cik":null,"owner_name":"STONEPINE CAPITAL, L.P.; Stonepine Capital Management, LLC; Plexico Jon M; LYNCH TIMOTHY P","owner_display_name":"STONEPINE CAPITAL, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1250000.0,"shares_display":"1,250,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":3849711.0,"shares_owned_after_display":"3,849,711","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-17","filed_date":"2017-03-21","scope":"insider"},{"id":2386261,"accession":"0001140361-16-079947","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-16-079947","line_url":"/filing/0001140361-16-079947#line-3","is_derivative":false,"issuer_cik":"0000827809","issuer_name":"QLT INC/BC","issuer_ticker":"QLTI","issuer_name_source":null,"issuer_url":"/issuer/0000827809","owner_cik":"0001370042","owner_name":"STONEPINE CAPITAL, L.P.","owner_display_name":"STONEPINE CAPITAL, L.P.","owner_url":"/insider/0001370042","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14928.0,"shares_display":"14,928","price_per_share":1.55,"price_display":"1.55","price_state":"stated","total_value":23138.4,"total_display":"23,138.40","total_whole":"23,138","shares_owned_after":5778496.0,"shares_owned_after_display":"5,778,496","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-15","filed_date":"2016-09-15","scope":"insider"},{"id":2386256,"accession":"0001140361-16-079947","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-16-079947","line_url":"/filing/0001140361-16-079947#line-2","is_derivative":false,"issuer_cik":"0000827809","issuer_name":"QLT INC/BC","issuer_ticker":"QLTI","issuer_name_source":null,"issuer_url":"/issuer/0000827809","owner_cik":"0001370042","owner_name":"STONEPINE CAPITAL, L.P.","owner_display_name":"STONEPINE CAPITAL, L.P.","owner_url":"/insider/0001370042","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":56864.0,"shares_display":"56,864","price_per_share":1.5523,"price_display":"1.55","price_state":"stated","total_value":88269.9872,"total_display":"88,269.99","total_whole":"88,270","shares_owned_after":5763568.0,"shares_owned_after_display":"5,763,568","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-14","filed_date":"2016-09-15","scope":"insider"},{"id":2386248,"accession":"0001140361-16-079947","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-16-079947","line_url":"/filing/0001140361-16-079947#line-1","is_derivative":false,"issuer_cik":"0000827809","issuer_name":"QLT INC/BC","issuer_ticker":"QLTI","issuer_name_source":null,"issuer_url":"/issuer/0000827809","owner_cik":"0001370042","owner_name":"STONEPINE CAPITAL, L.P.","owner_display_name":"STONEPINE CAPITAL, L.P.","owner_url":"/insider/0001370042","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":61704.0,"shares_display":"61,704","price_per_share":1.5423,"price_display":"1.54","price_state":"stated","total_value":95166.0792,"total_display":"95,166.08","total_whole":"95,166","shares_owned_after":5706704.0,"shares_owned_after_display":"5,706,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-13","filed_date":"2016-09-15","scope":"insider"},{"id":3147382,"accession":"0001437749-16-034195","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-16-034195","line_url":"/filing/0001437749-16-034195#line-1","is_derivative":false,"issuer_cik":"0000879682","issuer_name":"VIVEVE MEDICAL, INC.","issuer_ticker":"VIVE","issuer_name_source":null,"issuer_url":"/issuer/0000879682","owner_cik":null,"owner_name":"Stonepine Capital Management, LLC; LYNCH TIMOTHY P; STONEPINE CAPITAL, L.P.; Plexico Jon M","owner_display_name":"Stonepine Capital Management, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300000.0,"shares_display":"300,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":1500000.0,"total_display":"1,500,000.00","total_whole":"1,500,000","shares_owned_after":2599711.0,"shares_owned_after_display":"2,599,711","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-17","filed_date":"2016-06-21","scope":"insider"},{"id":8906147,"accession":"0001140361-15-042903","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-15-042903","line_url":"/filing/0001140361-15-042903#line-1","is_derivative":false,"issuer_cik":"0000879682","issuer_name":"VIVEVE MEDICAL, INC.","issuer_ticker":"VIVMF","issuer_name_source":null,"issuer_url":"/issuer/0000879682","owner_cik":"0001370042","owner_name":"STONEPINE CAPITAL, L.P.","owner_display_name":"STONEPINE CAPITAL, L.P.","owner_url":"/insider/0001370042","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2857142.0,"shares_display":"2,857,142","price_per_share":0.7,"price_display":"0.70","price_state":"stated","total_value":1999999.4,"total_display":"1,999,999.40","total_whole":"1,999,999","shares_owned_after":18397682.0,"shares_owned_after_display":"18,397,682","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-24","filed_date":"2015-11-25","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":24,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":22,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":24},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000827809","name":"NOVELION THERAPEUTICS INC.","url":"/issuer/0000827809","role":"Ten percent owner","n_filings":5,"first_seen":"2016-09-15","last_seen":"2019-12-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001251769","name":"Apollo Endosurgery, Inc.","url":"/issuer/0001251769","role":"Ten percent owner","n_filings":7,"first_seen":"2017-12-22","last_seen":"2018-12-31"},{"type":"issuer","type_label":"ISSUER","cik":"0000879682","name":"VIVEVE MEDICAL, INC.","url":"/issuer/0000879682","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2015-11-25","last_seen":"2017-03-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001370042","retrieved_at":"2026-08-23T10:55:28+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}